Interestingly, 3 of the 5 cases (60%) carrying 2 rare stop-gain, splice site, frameshift, or missense variants in MND genes (including C9orf72 expansions) had a bulbar site of onset, which is higher than the 29% observed across all MND cases in the cohort. Here, C9orf72 is linked to mild neurocognitive disorder.